CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
April 2015—In an exclusive arrangement with Arotec Diagnostics, the Binding Site has added five antibodies to its line of in vitro diagnostic manufacturing and research products: Anti-NGAL, Anti-Calprotectin, Anti-Azurocidin, Anti-Neutrophil Elastase, and Anti-Neutrophil Lactoferrin.
Derived and sourced from goat of New Zealand origin, with human neutrophils used as the immunogen, these novel antibodies exhibit exceptional specificity while demonstrating high levels of product purity, as assessed by SDS gel electrophoresis. Expressly designed for use as a critical component in immunocytochemistry, Western blot, and ELISA-based immunoassay testing procedures, the antibodies aim to offer exceptional shelf-life stability and lot-to-lot consistency. They are available in a standard packaging format size of 1 × 1.0 mg, with customer-specific and bulk configurations also available.
Binding Site , 800-633-4484